Systematic overview of cost–effectiveness thresholds in ten countries across four continents
| Autor: | Beate Jahn, Martina Lackner, Karl Pugner, Ansgar Hebborn, Petra Schnell-Inderst, Gaby Sroczynski, Andras Fehervary, Imke Schall, Ruth Schwarzer, Bernhard Bornschein, Uwe Siebert, Nikolai Muehlberger, Ursula Rochau, K.R. Saverno, Diana I. Brixner, Magdalena Flatscher-Thoeni |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Economic growth
Internationality Cost effectiveness business.industry Cost-Benefit Analysis Health Policy Nice Willingness to pay Humans Medicine Quality-Adjusted Life Years Health Expenditures business computer Health policy Reimbursement Individual country computer.programming_language Demography Rank correlation |
| Zdroj: | Journal of Comparative Effectiveness Research. 4:485-504 |
| ISSN: | 2042-6313 2042-6305 |
| DOI: | 10.2217/cer.15.38 |
| Popis: | Aim: To provide an overview of thresholds for incremental cost–effectiveness ratios (ICERs) representing willingness-to-pay (WTP) across multiple countries and insights into exemptions pertaining to the ICER (e.g., cancer). To compare ICER thresholds to individual country's estimated ability-to-pay. Materials & methods: We included AHRQ/USA, BIQG-GOEG/Austria, CADTH/Canada, DAHTA@DIMDI/Germany, DECIT-CGATS/Brazil, HAS/France, HITAP/Thailand, IQWiG/Germany, LBI-HTA/Austria, MSAC/Australia, NICE/England/Wales and SBU/Sweden. ICER thresholds were derived from systematic literature/website search/expert surveys. WTP was compared with ATP using Spearman's rank correlation. Results: Two general and explicitly acknowledged thresholds (England/Wales, Thailand), implicit thresholds in six countries and different ICER thresholds/decision-making rules in oncology were identified. Correlation between WTP and ability-to-pay was moderate. Discussion: Our overview supports country-specific discussions on WTP and on how to define value(s) within societies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|